China has become the world's second largest medical device market, and is still increasing at a rate of about 10% per year. At the 272nd China Engineering Science and Technology Forum on Cardiovascular Innovation Medical Devices held recently, Hu Shengshou, director of the National Cardiovascular Disease Center, said that cardiovascular disease is an important area of medical device innovation. At present, cardiovascular disease has become the first cause of death in China. There are 290 million patients with cardiovascular disease in China, and about 3.7 million people die of cardiovascular disease every year. Hu Shengshou said: under the guidance of the national innovation-driven development strategy, new drugs, new devices, and intelligent tools are emerging in endlessly, and the scientific supervision is facing enormous challenges. It is necessary to do a good job at the top level and improve the "regulatory scientific system." Strengthen the capacity building at all levels from R & D to regulation. At present, cardiovascular medical devices focus on artificial heart, degradable stents, interventional valves and so on. Among them, artificial heart is one of the medical devices with the highest gold content. The third generation artificial heart is expected to enter clinical research next month.